Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
In Vitro Cell Dev Biol Anim ; 60(5): 521-534, 2024 May.
Article in English | MEDLINE | ID: mdl-38169039

ABSTRACT

Trisomy 12 is one of the most frequent chromosomal abnormalities in cultured human pluripotent stem cells (hPSCs). Although potential oncogenic properties and augmented cell cycle caused by trisomy 12 have been reported, the consequences of trisomy 12 in terms of cell differentiation, which is the basis for regenerative medicine, drug development, and developmental biology studies, have not yet been investigated. Here, we report that trisomy 12 compromises the mesendodermal differentiation of hPSCs. We identified sublines of hPSCs carrying trisomy 12 after their prolonged culture. Transcriptome analysis revealed that these hPSC sublines carried abnormal gene expression patterns in specific signaling pathways in addition to cancer-related cell cycle pathways. These hPSC sublines showed a lower propensity for mesendodermal differentiation in embryoid bodies cultured in a serum-free medium. BMP4-induced exit from the self-renewal state was impaired in the trisomy 12 hPSC sublines, with less upregulation of key transcription factor gene expression. As a consequence, the differentiation efficiency of hematopoietic and hepatic lineages was also impaired in the trisomy 12 hPSC sublines. We reveal that trisomy 12 disrupts the genome-wide expression patterns that are required for proper mesendodermal differentiation.


Subject(s)
Cell Differentiation , Chromosomes, Human, Pair 12 , Pluripotent Stem Cells , Trisomy , Humans , Cell Differentiation/genetics , Trisomy/genetics , Chromosomes, Human, Pair 12/genetics , Pluripotent Stem Cells/metabolism , Pluripotent Stem Cells/cytology , Mesoderm/cytology , Endoderm/cytology , Endoderm/metabolism , Bone Morphogenetic Protein 4/metabolism , Bone Morphogenetic Protein 4/genetics , Embryoid Bodies/cytology , Embryoid Bodies/metabolism , Cell Line , Signal Transduction/genetics
2.
Exp Cell Res ; 352(2): 333-345, 2017 03 15.
Article in English | MEDLINE | ID: mdl-28215634

ABSTRACT

Limited growth potential, narrow ranges of sources, and difference in variability and functions from batch to batch of primary hepatocytes cause a problem for predicting drug-induced hepatotoxicity during drug development. Human pluripotent stem cell (hPSC)-derived hepatocyte-like cells in vitro are expected as a tool for predicting drug-induced hepatotoxicity. Several studies have already reported efficient methods for differentiating hPSCs into hepatocyte-like cells, however its differentiation process is time-consuming, labor-intensive, cost-intensive, and unstable. In order to solve this problem, expansion culture for hPSC-derived hepatic progenitor cells, including hepatic stem cells and hepatoblasts which can self-renewal and differentiate into hepatocytes should be valuable as a source of hepatocytes. However, the mechanisms of the expansion of hPSC-derived hepatic progenitor cells are not yet fully understood. In this study, to isolate hPSC-derived hepatic progenitor cells, we tried to develop serum-free growth factor defined culture conditions using defined components. Our culture conditions were able to isolate and grow hPSC-derived hepatic progenitor cells which could differentiate into hepatocyte-like cells through hepatoblast-like cells. We have confirmed that the hepatocyte-like cells prepared by our methods were able to increase gene expression of cytochrome P450 enzymes upon encountering rifampicin, phenobarbital, or omeprazole. The isolation and expansion of hPSC-derived hepatic progenitor cells in defined culture conditions should have advantages in terms of detecting accurate effects of exogenous factors on hepatic lineage differentiation, understanding mechanisms underlying self-renewal ability of hepatic progenitor cells, and stably supplying functional hepatic cells.


Subject(s)
Cellular Reprogramming Techniques/methods , Embryonic Stem Cells/cytology , Hepatocytes/cytology , Pluripotent Stem Cells/cytology , Cell Differentiation , Cells, Cultured , Culture Media, Serum-Free/pharmacology , Cytochrome P-450 Enzyme System/genetics , Cytochrome P-450 Enzyme System/metabolism , Embryonic Stem Cells/drug effects , Embryonic Stem Cells/metabolism , Hepatocytes/drug effects , Hepatocytes/metabolism , Humans , Intercellular Signaling Peptides and Proteins/pharmacology , Pluripotent Stem Cells/drug effects , Pluripotent Stem Cells/metabolism
3.
Stem Cells Dev ; 25(24): 1884-1897, 2016 12 15.
Article in English | MEDLINE | ID: mdl-27733097

ABSTRACT

Functional hepatocytes derived from human pluripotent stem cells (hPSCs) have potential as tools for predicting drug-induced hepatotoxicity in the early phases of drug development. However, the propensity of hPSC lines to differentiate into specific lineages is reported to differ. The ability to predict low propensity of hPSCs to differentiate into hepatocytes would facilitate the selection of useful hPSC clones and substantially accelerate development of hPSC-derived hepatocytes for pharmaceutical research. In this study, we compared the expression of genes associated with hepatic differentiation in five hPSC lines including human ES cell line, H9, which is known to differentiate into hepatocytes, and an hPSC line reported with a poor propensity for hepatic differentiation. Genes distinguishing between undifferentiated hPSCs, hPSC-derived hepatoblast-like differentiated cells, and primary human hepatocytes were drawn by two-way cluster analysis. The order of expression levels of genes in undifferentiated hPSCs was compared with that in hPSC-derived hepatoblast-like cells. Three genes were selected as predictors of low propensity for hepatic differentiation. Expression of these genes was investigated in 23 hPSC clones. Review of representative cells by induction of hepatic differentiation suggested that low prediction scores were linked with low hepatic differentiation. Thus, our model using gene expression ranking and bioinformatic analysis could reasonably predict poor differentiation propensity of hPSC lines.


Subject(s)
Cell Differentiation/genetics , Gene Expression Regulation , Hepatocytes/cytology , Pluripotent Stem Cells/cytology , Cell Line , Cell Lineage/genetics , Cluster Analysis , Endoderm/cytology , Gene Expression Profiling , Genetic Association Studies , Hepatocytes/metabolism , Humans , Pluripotent Stem Cells/metabolism
4.
Sci Rep ; 6: 34009, 2016 Sep 26.
Article in English | MEDLINE | ID: mdl-27667091

ABSTRACT

Given the difficulties inherent in maintaining human pluripotent stem cells (hPSCs) in a healthy state, hPSCs should be routinely characterized using several established standard criteria during expansion for research or therapeutic purposes. hPSC colony morphology is typically considered an important criterion, but it is not evaluated quantitatively. Thus, we designed an unbiased method to evaluate hPSC colony morphology. This method involves a combination of automated non-labelled live-cell imaging and the implementation of morphological colony analysis algorithms with multiple parameters. To validate the utility of the quantitative evaluation method, a parent cell line exhibiting typical embryonic stem cell (ESC)-like morphology and an aberrant hPSC subclone demonstrating unusual colony morphology were used as models. According to statistical colony classification based on morphological parameters, colonies containing readily discernible areas of differentiation constituted a major classification cluster and were distinguishable from typical ESC-like colonies; similar results were obtained via classification based on global gene expression profiles. Thus, the morphological features of hPSC colonies are closely associated with cellular characteristics. Our quantitative evaluation method provides a biological definition of 'hPSC colony morphology', permits the non-invasive monitoring of hPSC conditions and is particularly useful for detecting variations in hPSC heterogeneity.

5.
Stem Cells Transl Med ; 5(3): 275-81, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26819254

ABSTRACT

Mitochondrial oxidative phosphorylation is a major source of cellular ATP. Its usage as an energy source varies, not only according to the extracellular environment, but also during development and differentiation, as indicated by the reported changes in the flux ratio of glycolysis to oxidative phosphorylation during embryonic stem (ES) cell differentiation. The fluorescent probe JC-1 allows visualization of changes in the mitochondrial membrane potential produced by oxidative phosphorylation. Strong JC-1 signals were localized in the differentiated cells located at the edge of H9 ES colonies that expressed vimentin, an early differentiation maker. The JC-1 signals were further intensified when individual adjacent colonies were in contact with each other. Time-lapse analyses revealed that JC-1-labeled H9 cells under an overconfluent condition were highly differentiated after subculture, suggesting that monitoring oxidative phosphorylation in live cells might facilitate the prediction of induced pluripotent stem cells, as well as ES cells, that are destined to lose their undifferentiated potency.


Subject(s)
Cell Differentiation/genetics , Human Embryonic Stem Cells/metabolism , Induced Pluripotent Stem Cells/metabolism , Oxidative Phosphorylation , Adenosine Triphosphate , Cell Line , Cell Tracking/methods , Energy Metabolism , Fluorescent Dyes/metabolism , Human Embryonic Stem Cells/cytology , Humans , Induced Pluripotent Stem Cells/cytology , Membrane Potential, Mitochondrial , Mitochondria/metabolism , Vimentin/biosynthesis
6.
In Vitro Cell Dev Biol Anim ; 51(8): 769-75, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25898826

ABSTRACT

Neural differentiation is an important target of human embryonic stem cells, which provide a source for cell-based therapy, developmental biology, and pharmaceutical research. Previous studies revealed that inhibition of the bone morphogenetic protein is required for neural induction from human embryonic stem cells. On the contrary, the functions of fibroblast growth factors and Activin/Nodal signaling are controversial. Fibroblast growth factor-2 and Activin/Nodal pathways exert divergent influences on human embryonic stem cell concerning the maintenance of both pluripotency and cellular differentiation. We hypothesized that the combination of fibroblast growth factor-2 and Activin A at various concentrations synergistically exerts diverse effects on cell differentiation. To determine the effects of fibroblast growth factor-2 and Activin A on cellular differentiation into neural lineages, we examined the expression of neural differentiation markers in human embryonic stem cells treated with fibroblast growth factor-2 and/or Activin A at various concentrations in a growth factor-defined serum-free medium in short-term culture. In this study, we provide evidence that fibroblast growth factor-2 and Activin A synergistically regulated the initiation of human embryonic stem cell differentiation into neural cell lineages even though human embryonic stem cells autonomously differentiate into neural cell lineages.


Subject(s)
Activins/pharmacology , Cell Differentiation/drug effects , Fibroblast Growth Factor 2/pharmacology , Pluripotent Stem Cells/drug effects , Cell Differentiation/physiology , Cell Lineage/drug effects , Cell Lineage/physiology , Dose-Response Relationship, Drug , Drug Synergism , Gene Expression Regulation, Developmental/drug effects , Gene Expression Regulation, Developmental/physiology , Humans , Neurons/cytology , Neurons/drug effects , Neurons/physiology , Pluripotent Stem Cells/physiology
7.
Sci Rep ; 4: 4646, 2014 Apr 11.
Article in English | MEDLINE | ID: mdl-24721898

ABSTRACT

Enzymes used for passaging human pluripotent stem cells (hPSCs) digest cell surface proteins, resulting in cell damage. Moreover, cell dissociation using divalent cation-free solutions causes apoptosis. Here we report that Mg(2+) and Ca(2+) control cell-fibronectin and cell-cell binding of hPSCs, respectively, under feeder- and serum-free culture conditions without enzyme. The hPSCs were detached from fibronectin-, vitronectin- or laminin-coated dishes in low concentrations of Mg(2+) and remained as large colonies in high concentrations of Ca(2+). Using enzyme-free solutions containing Ca(2+) without Mg(2+), we successfully passaged hPSCs as large cell clumps that showed less damage than cells passaged using a divalent cation-free solution or dispase. Under the same conditions, the undifferentiated and early-differentiated cells could also be harvested as a cell sheet without being split off. Our enzyme-free passage of hPSCs under a serum- and feeder-free culture condition reduces cell damage and facilitates easier and safer cultures of hPSCs.


Subject(s)
Cations, Divalent/metabolism , Pluripotent Stem Cells/cytology , Calcium/chemistry , Calcium/metabolism , Cations, Divalent/chemistry , Cell Differentiation , Cell Line , Cell Proliferation , Endopeptidases/metabolism , Fibronectins/metabolism , Humans , Karyotyping , Magnesium/chemistry , Magnesium/metabolism , Pluripotent Stem Cells/metabolism
8.
PLoS One ; 8(1): e54122, 2013.
Article in English | MEDLINE | ID: mdl-23349801

ABSTRACT

BACKGROUND: The self-renewal of human pluripotent stem (hPS) cells including embryonic stem and induced pluripotent stem cells have been reported to be supported by various signal pathways. Among them, fibroblast growth factor-2 (FGF-2) appears indispensable to maintain self-renewal of hPS cells. However, downstream signaling of FGF-2 has not yet been clearly understood in hPS cells. METHODOLOGY/PRINCIPAL FINDINGS: In this study, we screened a kinase inhibitor library using a high-throughput alkaline phosphatase (ALP) activity-based assay in a minimal growth factor-defined medium to understand FGF-2-related molecular mechanisms regulating self-renewal of hPS cells. We found that in the presence of FGF-2, an inhibitor of protein kinase C (PKC), GF109203X (GFX), increased ALP activity. GFX inhibited FGF-2-induced phosphorylation of glycogen synthase kinase-3ß (GSK-3ß), suggesting that FGF-2 induced PKC and then PKC inhibited the activity of GSK-3ß. Addition of activin A increased phosphorylation of GSK-3ß and extracellular signal-regulated kinase-1/2 (ERK-1/2) synergistically with FGF-2 whereas activin A alone did not. GFX negated differentiation of hPS cells induced by the PKC activator, phorbol 12-myristate 13-acetate whereas Gö6976, a selective inhibitor of PKCα, ß, and γ isoforms could not counteract the effect of PMA. Intriguingly, functional gene analysis by RNA interference revealed that the phosphorylation of GSK-3ß was reduced by siRNA of PKCδ, PKCε, and ζ, the phosphorylation of ERK-1/2 was reduced by siRNA of PKCε and ζ, and the phosphorylation of AKT was reduced by PKCε in hPS cells. CONCLUSIONS/SIGNIFICANCE: Our study suggested complicated cross-talk in hPS cells that FGF-2 induced the phosphorylation of phosphatidylinositol-3 kinase (PI3K)/AKT, mitogen-activated protein kinase/ERK-1/2 kinase (MEK), PKC/ERK-1/2 kinase, and PKC/GSK-3ß. Addition of GFX with a MEK inhibitor, U0126, in the presence of FGF-2 and activin A provided a long-term stable undifferentiated state of hPS cells even though hPS cells were dissociated into single cells for passage. This study untangles the cross-talk between molecular mechanisms regulating self-renewal and differentiation of hPS cells.


Subject(s)
Cell Proliferation , Pluripotent Stem Cells/metabolism , Protein Kinase C-delta/metabolism , Protein Kinase C-epsilon/metabolism , Protein Kinase C/metabolism , Activins/pharmacology , Alkaline Phosphatase/metabolism , Blotting, Western , Carbazoles/pharmacology , Cell Line , Chromones/pharmacology , Extracellular Signal-Regulated MAP Kinases/metabolism , Fibroblast Growth Factor 2/pharmacology , Glycogen Synthase Kinase 3/metabolism , Glycogen Synthase Kinase 3 beta , Humans , Immunohistochemistry , Indoles/pharmacology , Maleimides/pharmacology , Morpholines/pharmacology , Phosphatidylinositol 3-Kinases/metabolism , Phosphorylation/drug effects , Pluripotent Stem Cells/cytology , Protein Kinase C/genetics , Protein Kinase C-delta/genetics , Protein Kinase C-epsilon/genetics , Proto-Oncogene Proteins c-akt/metabolism , RNA Interference , Signal Transduction/drug effects , Tetradecanoylphorbol Acetate/pharmacology
10.
Yakugaku Zasshi ; 128(1): 51-60, 2008 Jan.
Article in Japanese | MEDLINE | ID: mdl-18176056

ABSTRACT

To create new in vitro culture models for extrapolating the cell response in vivo, we attempted to devise culture substrata of anchorage-dependent cells. The first substratum, tissue/organ sections for histopathology(TOSHI)-substratum was found to conserve both tissue composition and microarchitecture in an in vivo environment. Collagen vitrigel membrane, the second substratum investigated, possesses excellent strength and protein permeability. Both substrata were developed and utilized for the culture of various anchorage-dependent cells. TOSHI-substratum prepared from regenerative mouse livers after carbon tetrachloride intoxication efficiently induced the differentiation of mouse embryonic stem cells into hepatocyte-like cells. Also, the time-course cell behavior of two different cell lines on various TOSHI-substrata prepared from rat mature organs was successfully converted into a three-dimensional graph chart, i.e. a mathematical model. These data suggest that the analysis of interactions between different cell types and various TOSHI-substrata will play an important role for a novel approach to study both cellomics and histomics. Meanwhile, the collagen vitrigel membrane is easy to handle by forceps, resulting in double surface-culture of different cell types by the manipulation of two-dimensional cultures. In the crosstalk model between PC-12 pheochromocytoma cells and L929 fibroblasts, nerve growth factor secreted from L929 cells permeated the collagen vitrigel membrane and induced neurite outgrowth of PC-12 cells via a paracrine effect. Futhermore, the function of rat primary hepatocytes was well maintained on the collagen vitrigel membrane. These data suggest that the collagen vitrigel membrane-substratum has many advantages for the reconstruction of culture models.


Subject(s)
Collagen , Drug Design , Tissue Culture Techniques/methods , Animals , Humans , Membranes, Artificial , Mice , Models, Biological , Rats
11.
Biotechnol Appl Biochem ; 45(Pt 2): 59-64, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16674313

ABSTRACT

Adenoviral vectors are extensively used as gene-delivery vehicles in gene therapy. They are usually produced by HEK-293 cell (human embryonic kidney-293 cell) culture, which requires specially formulated serum-free medium, the cost of which is considerable or by supplementation with FBS (fetal bovine serum). The risk of infectious diseases such as BSE (bovine spongiform encephalopathy) and endogenous retrovirus derived from cattle is a serious concern. The present study reports the use of sericin protein derived from silkworm (Bombyx mori) as an effective supplement instead of FBS. Without FBS, HEK-293 cells significantly proliferated in the presence of 0.025-0.4% sericin, especially at 0.1%, but the effect was inferior to that of FBS. When a lower titre [MOI (multiplicity of infection) 0.03] of adenoviral vector pAxCAiLacZ was used as the inoculum, HEK-293 cells in the presence of 0.1% sericin produced a nearly 3-fold higher vector titre than culture in the presence of 5% (v/v) FBS. However, when a higher vector titre (MOI 3.7) was used as the inoculum, HEK-293 cells in the presence of sericin produced a slightly higher vector titre than in the presence of FBS, which might suggest that HEK-293 cells produce a maximum amount when a higher vector titre is used as the inoculum. These increases in vector production with sericin were confirmed by LacZ (beta-galactosidase reporter gene) activity assay. Supplementation with sericin decreased lactate dehydrogenase activity, an indicator of cell death, suggesting that sericin improved cell survival; hence, prolonging the culture period might be one of the reasons for increased vector production. On the basis of these results, sericin peptide seems to be a potent and effective alternative supplement for production of adenoviral vectors without such risks as BSE and retrovirus.


Subject(s)
Adenoviridae/genetics , Genetic Vectors , Sericins/pharmacology , Animals , Bombyx/chemistry , Cell Line , Cell Proliferation , Cell Survival , Culture Media, Serum-Free , Genetic Therapy , Humans , L-Lactate Dehydrogenase/metabolism , Lac Operon , Sericins/chemistry
12.
J Biosci Bioeng ; 100(6): 667-71, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16473778

ABSTRACT

We previously reported that sericin small (sericin-S), with a molecular weight that ranges from 5 to 100 kDa, is a cell culture supplement used to accelerate cell proliferation. In this study, a novel preparation method for sericin and several applications of sericin were examined. Sericin large, prepared under nonhydrolyzing conditions and ranging from 50 to 200 kDa, also accelerated cell proliferation, but its effects were inferior to those of sericin-S. Additional sericin preparations with various molecular weights that were differentially hydrolyzed were also tested but none of them was significantly superior to sericin-S, and neither were several recombinant sericin peptides. Sericin-S successfully accelerated the proliferation of hybridoma cells in various serum-free media, implying the mitogenic effect of sericin is independent from media. We also demonstrated that sericin-S successfully induced the proliferation of CTLL-2, an established T lymphocyte cell line, under IL-2 starvation conditions. These results indicate that sericin, particularly sericin-S, improves serum-free mammalian cell culture.


Subject(s)
Bombyx/metabolism , Cell Culture Techniques/methods , Hybridomas/cytology , Hybridomas/physiology , Mitosis/physiology , Sericins/metabolism , Sericins/pharmacology , Animals , Bombyx/genetics , Cell Proliferation/drug effects , Culture Media, Serum-Free/chemistry , Culture Media, Serum-Free/metabolism , Interleukin-2/deficiency , Mice , Mitosis/drug effects , Protein Engineering/methods , Recombinant Proteins/metabolism , Recombinant Proteins/pharmacology , Sericins/genetics , Sericins/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...